Cefotaxime
- Product NDC
- 64679-986
- 11-digit product format
- 646790986
- Labeler code
- 64679
- Product ID
- 64679-986_4d51bfa3-dadf-44bc-a2b6-75f477945341
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefotaxime
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Wockhardt USA LLC.
- Application
- ANDA065197
- Marketing category
- ANDA
- Marketing start
- 2008-08-29
- Marketing end
- 0000-00-00
- Substance
- CEFOTAXIME SODIUM
- Active strength
- 1 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 64679-986-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2bba-a910-e053-dadaa90a0b85 | Prescribing information Cefotaxime for Injection, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefotaxime for injection and other antibacterial drugs, cefotaxime for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. |
| 64679-986-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2bba-a910-e053-dadaa90a0b85 | Prescribing information Cefotaxime for Injection, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefotaxime for injection and other antibacterial drugs, cefotaxime for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. |
| 64679-986-03 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2bba-a910-e053-dadaa90a0b85 | Prescribing information Cefotaxime for Injection, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefotaxime for injection and other antibacterial drugs, cefotaxime for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. |
| 64679-986-04 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2bba-a910-e053-dadaa90a0b85 | Prescribing information Cefotaxime for Injection, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefotaxime for injection and other antibacterial drugs, cefotaxime for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64679-986-01 | Cefotaxime | 1 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 1 | | 4 |
| 64679-986-02 | Cefotaxime | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | | 4 |
| 64679-986-03 | Cefotaxime | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | | 4 |
| 64679-986-04 | Cefotaxime | 50 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 50 | | 4 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64679-986 | CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WOCKHARDT USA LLC.] | 4 | Legacy NDC, 4 package rows | 20200125_f3c5895f-f54b-43d4-9b38-7bfbdf8335b7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 64679-986-01 | 64679098601 | 1 in 1 CARTON | Historical |
| 64679-986-02 | 64679098602 | 10 in 1 CARTON | Historical |
| 64679-986-03 | 64679098603 | 25 in 1 CARTON | Historical |
| 64679-986-04 | 64679098604 | 50 in 1 CARTON | Historical |